Literature DB >> 26168268

B56δ-related protein phosphatase 2A dysfunction identified in patients with intellectual disability.

Gunnar Houge, Dorien Haesen, Lisenka E L M Vissers, Sarju Mehta, Michael J Parker, Michael Wright, Julie Vogt, Shane McKee, John L Tolmie, Nuno Cordeiro, Tjitske Kleefstra, Marjolein H Willemsen, Margot R F Reijnders, Siren Berland, Eli Hayman, Eli Lahat, Eva H Brilstra, Koen L I van Gassen, Evelien Zonneveld-Huijssoon, Charlotte I de Bie, Alexander Hoischen, Evan E Eichler, Rita Holdhus, Vidar M Steen, Stein Ove Døskeland, Matthew E Hurles, David R FitzPatrick, Veerle Janssens.   

Abstract

Here we report inherited dysregulation of protein phosphatase activity as a cause of intellectual disability (ID). De novo missense mutations in 2 subunits of serine/threonine (Ser/Thr) protein phosphatase 2A (PP2A) were identified in 16 individuals with mild to severe ID, long-lasting hypotonia, epileptic susceptibility, frontal bossing, mild hypertelorism, and downslanting palpebral fissures. PP2A comprises catalytic (C), scaffolding (A), and regulatory (B) subunits that determine subcellular anchoring, substrate specificity, and physiological function. Ten patients had mutations within a highly conserved acidic loop of the PPP2R5D-encoded B56δ regulatory subunit, with the same E198K mutation present in 6 individuals. Five patients had mutations in the PPP2R1A-encoded scaffolding Aα subunit, with the same R182W mutation in 3 individuals. Some Aα cases presented with large ventricles, causing macrocephaly and hydrocephalus suspicion, and all cases exhibited partial or complete corpus callosum agenesis. Functional evaluation revealed that mutant A and B subunits were stable and uncoupled from phosphatase activity. Mutant B56δ was A and C binding-deficient, while mutant Aα subunits bound B56δ well but were unable to bind C or bound a catalytically impaired C, suggesting a dominant-negative effect where mutant subunits hinder dephosphorylation of B56δ-anchored substrates. Moreover, mutant subunit overexpression resulted in hyperphosphorylation of GSK3β, a B56δ-regulated substrate. This effect was in line with clinical observations, supporting a correlation between the ID degree and biochemical disturbance.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26168268      PMCID: PMC4623570          DOI: 10.1172/JCI79860

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  46 in total

1.  PKA, PKC, and the protein phosphatase 2A influence HAND factor function: a mechanism for tissue-specific transcriptional regulation.

Authors:  Beth A Firulli; Marthe J Howard; Jennifer R McDaid; Leanne McIlreavey; Karen M Dionne; Victoria E Centonze; Peter Cserjesi; David M Virshup; Anthony B Firulli
Journal:  Mol Cell       Date:  2003-11       Impact factor: 17.970

Review 2.  Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis.

Authors:  Volker Brinkmann; Andreas Billich; Thomas Baumruker; Peter Heining; Robert Schmouder; Gordon Francis; Shreeram Aradhye; Pascale Burtin
Journal:  Nat Rev Drug Discov       Date:  2010-10-29       Impact factor: 84.694

3.  The B56 family of protein phosphatase 2A (PP2A) regulatory subunits encodes differentiation-induced phosphoproteins that target PP2A to both nucleus and cytoplasm.

Authors:  B McCright; A M Rivers; S Audlin; D M Virshup
Journal:  J Biol Chem       Date:  1996-09-06       Impact factor: 5.157

4.  Genome sequencing identifies major causes of severe intellectual disability.

Authors:  Christian Gilissen; Jayne Y Hehir-Kwa; Djie Tjwan Thung; Maartje van de Vorst; Bregje W M van Bon; Marjolein H Willemsen; Michael Kwint; Irene M Janssen; Alexander Hoischen; Annette Schenck; Richard Leach; Robert Klein; Rick Tearle; Tan Bo; Rolph Pfundt; Helger G Yntema; Bert B A de Vries; Tjitske Kleefstra; Han G Brunner; Lisenka E L M Vissers; Joris A Veltman
Journal:  Nature       Date:  2014-06-04       Impact factor: 49.962

5.  Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomas.

Authors:  Melissa K McConechy; Michael S Anglesio; Steve E Kalloger; Winnie Yang; Janine Senz; Christine Chow; Alireza Heravi-Moussavi; Gregg B Morin; Anne-Marie Mes-Masson; Mark S Carey; Jessica N McAlpine; Janice S Kwon; Leah M Prentice; Niki Boyd; Sohrab P Shah; C Blake Gilks; David G Huntsman
Journal:  J Pathol       Date:  2011-03-07       Impact factor: 7.996

6.  Somatic mutations of PPP2R1A in ovarian and uterine carcinomas.

Authors:  Ie-Ming Shih; Pradeep K Panuganti; Kuan-Tin Kuo; Tsui-Lien Mao; Elisabetta Kuhn; Sian Jones; Victor E Velculescu; Robert J Kurman; Tian-Li Wang
Journal:  Am J Pathol       Date:  2011-02-26       Impact factor: 4.307

7.  Megalencephaly syndromes and activating mutations in the PI3K-AKT pathway: MPPH and MCAP.

Authors:  Ghayda M Mirzaa; Jean-Baptiste Rivière; William B Dobyns
Journal:  Am J Med Genet C Semin Med Genet       Date:  2013-04-16       Impact factor: 3.908

8.  Structure and function of the PP2A-shugoshin interaction.

Authors:  Zheng Xu; Bulent Cetin; Martin Anger; Uhn Soo Cho; Wolfgang Helmhart; Kim Nasmyth; Wenqing Xu
Journal:  Mol Cell       Date:  2009-08-28       Impact factor: 17.970

9.  Structure of a protein phosphatase 2A holoenzyme: insights into B55-mediated Tau dephosphorylation.

Authors:  Yanhui Xu; Yu Chen; Ping Zhang; Philip D Jeffrey; Yigong Shi
Journal:  Mol Cell       Date:  2008-09-26       Impact factor: 17.970

Review 10.  "Selfish spermatogonial selection": a novel mechanism for the association between advanced paternal age and neurodevelopmental disorders.

Authors:  Anne Goriely; John J McGrath; Christina M Hultman; Andrew O M Wilkie; Dolores Malaspina
Journal:  Am J Psychiatry       Date:  2013-06       Impact factor: 18.112

View more
  34 in total

Review 1.  Targeting PP2A in cancer: Combination therapies.

Authors:  Sahar Mazhar; Sarah E Taylor; Jaya Sangodkar; Goutham Narla
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2018-09-01       Impact factor: 4.739

Review 2.  cAMP regulation of protein phosphatases PP1 and PP2A in brain.

Authors:  Shannon N Leslie; Angus C Nairn
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2018-09-18       Impact factor: 4.739

3.  A genotype-first approach identifies an intellectual disability-overweight syndrome caused by PHIP haploinsufficiency.

Authors:  Sandra Jansen; Alexander Hoischen; Bradley P Coe; Gemma L Carvill; Hilde Van Esch; Daniëlle G M Bosch; Ulla A Andersen; Carl Baker; Marijke Bauters; Raphael A Bernier; Bregje W van Bon; Hedi L Claahsen-van der Grinten; Jozef Gecz; Christian Gilissen; Lucia Grillo; Anna Hackett; Tjitske Kleefstra; David Koolen; Malin Kvarnung; Martin J Larsen; Carlo Marcelis; Fiona McKenzie; Marie-Lorraine Monin; Caroline Nava; Janneke H Schuurs-Hoeijmakers; Rolph Pfundt; Marloes Steehouwer; Servi J C Stevens; Connie T Stumpel; Fleur Vansenne; Mirella Vinci; Maartje van de Vorst; Petra de Vries; Kali Witherspoon; Joris A Veltman; Han G Brunner; Heather C Mefford; Corrado Romano; Lisenka E L M Vissers; Evan E Eichler; Bert B A de Vries
Journal:  Eur J Hum Genet       Date:  2017-12-05       Impact factor: 4.246

Review 4.  A Clinical Review of Generalized Overgrowth Syndromes in the Era of Massively Parallel Sequencing.

Authors:  Benjamin Kamien; Anne Ronan; Gemma Poke; Ingrid Sinnerbrink; Gareth Baynam; Michelle Ward; William T Gibson; Tracy Dudding-Byth; Rodney J Scott
Journal:  Mol Syndromol       Date:  2018-01-25

Review 5.  Non-redox cycling mechanisms of oxidative stress induced by PM metals.

Authors:  James M Samet; Hao Chen; Edward R Pennington; Philip A Bromberg
Journal:  Free Radic Biol Med       Date:  2019-12-23       Impact factor: 7.376

6.  A De Novo Variant Identified in the PPP2R1A Gene in an Infant Induces Neurodevelopmental Abnormalities.

Authors:  Yanghui Zhang; Haoxian Li; Hua Wang; Zhengjun Jia; Hui Xi; Xiao Mao
Journal:  Neurosci Bull       Date:  2019-09-17       Impact factor: 5.203

7.  A Newborn with Severe Ventriculomegaly: Expanding the PPP2R1A Gene Mutation Phenotype.

Authors:  Alexandra Wallace; Paul Caruso; Amel Karaa
Journal:  J Pediatr Genet       Date:  2019-06-12

8.  De novo missense variants in PPP2R5D are associated with intellectual disability, macrocephaly, hypotonia, and autism.

Authors:  Linshan Shang; Lindsay B Henderson; Megan T Cho; Donald S Petrey; Chin-To Fong; Katrina M Haude; Natasha Shur; Julie Lundberg; Natalie Hauser; Jason Carmichael; Jeffrey Innis; Jane Schuette; Yvonne W Wu; Shailesh Asaikar; Margaret Pearson; Leandra Folk; Kyle Retterer; Kristin G Monaghan; Wendy K Chung
Journal:  Neurogenetics       Date:  2015-11-17       Impact factor: 2.660

9.  Reduction of protein phosphatase 2A (PP2A) complexity reveals cellular functions and dephosphorylation motifs of the PP2A/B'δ holoenzyme.

Authors:  Chian Ju Jong; Ronald A Merrill; Emily M Wilkerson; Laura E Herring; Lee M Graves; Stefan Strack
Journal:  J Biol Chem       Date:  2020-03-10       Impact factor: 5.157

10.  De Novo Mutations Affecting the Catalytic Cα Subunit of PP2A, PPP2CA, Cause Syndromic Intellectual Disability Resembling Other PP2A-Related Neurodevelopmental Disorders.

Authors:  Sara Reynhout; Sandra Jansen; Dorien Haesen; Siska van Belle; Sonja A de Munnik; Ernie M H F Bongers; Jolanda H Schieving; Carlo Marcelis; Jeanne Amiel; Marlène Rio; Heather Mclaughlin; Roger Ladda; Susan Sell; Marjolein Kriek; Cacha M P C D Peeters-Scholte; Paulien A Terhal; Koen L van Gassen; Nienke Verbeek; Sonja Henry; Jessica Scott Schwoerer; Saleem Malik; Nicole Revencu; Carlos R Ferreira; Ellen Macnamara; Hilde M H Braakman; Elise Brimble; Maura R Z Ruzhnikov; Matias Wagner; Philip Harrer; Dagmar Wieczorek; Alma Kuechler; Barak Tziperman; Ortal Barel; Bert B A de Vries; Christopher T Gordon; Veerle Janssens; Lisenka E L M Vissers
Journal:  Am J Hum Genet       Date:  2018-12-27       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.